Phillips Sawyer presents on uses of history in contemporary regulatory policymaking
Associate Professor Laura Phillips Sawyer presented on the uses of history in contemporary regulatory policymaking at the
The University of Georgia School of Law is redefining what it means to be a great national public law school. The following news items demonstrate the School of Law’s commitment to producing World-class Scholarship advancing the rule of law, while also supporting the school’s vision to be the best return on investment in legal education.
Associate Professor Laura Phillips Sawyer presented on the uses of history in contemporary regulatory policymaking at the
Brumby Distinguished Professor in First Amendment Law Sonja R.
Brock Associate Professor in Professional Responsibility Nathan S. Chapman was featured on Reason.com relating to the case Ramirez v.
University Professor & Kilpatrick Chair of Corporate Finance and Securities Law Usha Rodrigues presented "Behind the (SPAC) Scenes" at the 2021 Berkeley Forum for Corporate Governance
Rogers Chair of Law Emerita Camilla E.
Associate Professor Laura Phillips Sawyer presented on "Myths and Facts: The Progressive Era and Populist Expressions of Antitrust" as part of a University of So
Distinguished Research Professor & Shackelford Distinguished Professor in Taxation Law Emeritus Walter Hellerstein presented as part of a panel titled “VAT and the Digital Economy” organized by the International Moneta
Distinguished Research Professor & Shackelford Distinguished Professor in Taxation Law Emeritus Walter Hellerstein published "Does the Supreme Court's Decision in Wayfair Apply Retroactively?" in 102 Tax Notes State 715
Hosch Professor & Meigs Distinguished Teaching Professor Lori A. Ringhand presented on recent developments in election law as part of an University of Chicago Women+ in Law panel during November.
Callaway Chair Elizabeth Chamblee Burch was featured in The New York Times regarding her thoughts on the Oklahoma Supreme Court's decision overturning a ruling against drugmaker Johnson & Johnson.